§01 Browse › RAD-140

RAD-140

Testolone RAD RAD-140
Moderate Suppression
Anabolic / Androgenic
100 10
10.0:1 vs testosterone baseline
Aromatizes No
Hepatotoxic No
Oral Yes
Suppression moderate
PCT Required

RAD-140 (Testolone) is often promoted as “oral Testosterone” for its strong anabolic effect with minimal androgenic or estrogenic conversion. Pre-clinical studies show an anabolic:androgenic ratio of ~10:1, giving sizeable muscle and strength gains while sparing the prostate and hairline.

Protocol Why Use It Comparison Safety
Warning
Elevated liver enzymes reported at high doses · Can markedly suppress natural testosterone
Read This First
Before you plan around RAD-140, ground the basics.
RAD-140 is easier to misuse when bloodwork, recovery, or category context is skipped.
beginner The Philosophy and Practice of Harm Reduction 9 min read intermediate SARMs, Prohormones, and Novel Compounds 13 min read beginner Understanding Your Bloodwork 11 min read SARMs Before You Start
Why people use it

RAD-140 is usually chosen when the user wants one of the more aggressive SARMs for strength and visual effect. It attracts people who want something that feels steroid-like without openly moving into injectable steroid territory.

The draw is dryness plus obvious gym performance. It can create a sharper, harder look than wetter compounds while still moving strength fast enough that users feel the protocol is “working.”

Protocol & usage

Administration: Oral compound. Most users take it with a fixed daily schedule rather than chasing short-term effect swings.

Cycle context: Treat this like a suppressive research drug, not a harmless shortcut. Labs before and after matter even when the compound is marketed as mild.

Stop or reduce if: blood pressure climbs, sleep degrades, libido crashes, or labs move sharply in the wrong direction.

Timeline & expectations

RAD-140 usually shows itself through training output before it shows up as a major physique change. The first noticeable shift is often harder sessions, better top-end strength, and a drier look rather than rapid scale gain.

With a roughly 16-hour half-life, once-daily dosing is usually enough. Some users split doses for steadier subjective feel, but the bigger variable is not timing trickery. It is whether the user understands that suppression and lipid drift are still very real despite the SARM label.

Common mistakes

The biggest error is ignoring how real the suppression and lipid hit can be because the compound comes from the SARM side of the market. Another is stacking it with multiple other research compounds and losing the ability to attribute outcomes.

A second mistake is treating “dry” as “easy.” RAD does not aromatize, but that does not mean it is low-cost. Recovery planning, PCT, and bloodwork still matter.

Comparison notes

Compared with LGD-4033, RAD is often perceived as drier and more stimulating. Compared with Ostarine, it is much more likely to satisfy users chasing visible strength and size, but it also asks more from recovery.

Compared with S-23, RAD is usually a step down in harshness, but it still does not belong in a casual “starter SARM” mindset.

Safety & monitoring
Side effects

  • Natural suppression with reduced fertility and testicular output

  • Suppression, worsened lipids, and an evidence base that is much thinner than users assume

Monitoring

  • CBC / hematocrit

  • blood pressure

  • lipid panel

Avoid if

  • Uncontrolled hypertension or untreated cardiovascular disease

  • Pre-existing severe infertility concerns unless that risk is accepted and managed

Add to Cycle Builder Read: The Philosophy and Practice of Harm Reduction ← Browse